2024 Article Archive
Studies examine different responses to SARS-CoV-2 variants
– Two studies led by a researcher at UT Southwestern Medical Center show the effects of different SARS-CoV-2 variants on lung tissue, revealing what may cause some COVID-19 infections to be more severe than others.
Activating cerebellum shows promise for neurocognitive therapy
A study of mutant models of fragile X syndrome (FXS), a genetic disorder related to autism and intellectual disability, shows that activation of the cerebellum mitigates aberrant responses in sensory processing areas of the brain and improves neurodevelopmental behaviors.
UT Southwestern molecular biologist to receive O'Donnell Award from TAMEST
Vincent Tagliabracci, Ph.D., Associate Professor of Molecular Biology at UT Southwestern Medical Center, will receive the 2024 Edith and Peter O’Donnell Award in Biological Sciences from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST) for broadening the understanding of pseudokinases, a family of enzymes that play key roles in many physiological and pathological processes.
UT Southwestern joins Dallas and nation in mourning the loss of U.S. Rep. Eddie Bernice Johnson, inspirational leader and supporter
UT Southwestern Medical Center joined leaders in Dallas and across the nation in mourning the loss and honoring the legacy of U.S. Rep. Eddie Bernice Johnson, an inspirational leader who helped advance the medical center’s science, research, clinical care, and educational initiatives during her extraordinary career representing the area.
Study suggests key to antipsychotic drug-induced obesity
An increased concentration of the hormone leptin in fat cells is believed to be responsible for weight gain associated with antipsychotic drugs.
Robotic surgery is associated with improved outcomes for most colon cancer patients
Robotic surgery offers significant benefits over laparoscopic procedures for many patients undergoing colectomies for colon cancer, according to a study by UT Southwestern Medical Center.
Two-step screening strategy could reduce diabetic heart failure
A two-step screening protocol that combines clinical risk assessment with biomarker testing can more effectively identify which patients with Type 2 diabetes need medication to prevent heart failure, according to a study led by UT Southwestern Medical Center researchers.